top of page

Bio-Rad and 10x Genomics Settle Global Patent Disputes

July 28, 2021


Bio-Rad Laboratories Inc. ("Bio-Rad") and 10x Genomics, Inc. ("10x Genomics") have reportedly settled more than 20 separate patent disputes across a multitude of venues and jurisdictions. A copy of the settlement and patent cross-license agreement, which was filed with the SEC, can be accessed here.

Bio-Rad is based in Hercules, California and develops and manufactures products for the life sciences research and clinical diagnostic markets.

10x Genomics is based in Pleasanton, California and designs and manufactures gene sequencing technology used in scientific research. At least some of the founders of 10x Genomics were former employees of Bio-Rad.

Very generally, the patent disputes related to technology for the isolation of individual cells for genetic analysis on microscopic droplets.


Author: Jordan Scopa


Commenting has been turned off.
  • X
  • LinkedIn Icon (Goodmans IP)
  • Goodmans Intellectual Property Web
bottom of page